Skip to main content
Evidence-Based Answer · Kelda Molecular Database

Does Metformin Deplete Vitamin B12? What the Research Says

Yes, metformin significantly depletes vitamin B12 by interfering with the calcium-dependent absorption step in the terminal ileum. CTD documents 649 randomized trials across 1,319,946 patients with 301 meta-analyses confirming this as the most clinically important nutrient depletion from metformin. Between 10-30% of long-term users develop measurable B12 deficiency requiring supplementation.
Data sourced from CTD, PubMed, FAERS. How we verify this data →
Sources verified as of April 2026
[1]

The Answer

Yes, metformin depletes vitamin B12 — and this is one of the best-documented drug-nutrient interactions in modern medicine. Between 10-30% of patients on long-term metformin therapy develop clinically significant B12 deficiency, depending on dose and duration. CTD's molecular database documents 649 randomized controlled trials involving 1,319,946 patients, making metformin the most extensively studied oral diabetes medication in existence. With 301 meta-analyses synthesizing outcomes, the B12 depletion finding is replicated across virtually every major diabetic population studied. PubMed indexes 10,623 articles on metformin, and the B12 interaction features prominently in prescribing guidelines. The risk scales with dose and duration: patients taking 2,000+ mg daily for more than 3 years face the highest depletion rates. The danger is that B12 deficiency symptoms — numbness, tingling, cognitive decline — mimic diabetic neuropathy, leading clinicians to attribute the symptoms to diabetes progression rather than a correctable vitamin deficiency.

[2]

The Evidence

The landmark evidence comes from the Diabetes Prevention Program Outcomes Study (DPPOS), which followed metformin users for over a decade and confirmed dose- and duration-dependent B12 decline. CTD's 301 meta-analyses for metformin include multiple systematic reviews specifically analyzing the B12 interaction, consistently finding 10-30% prevalence of deficiency depending on how deficiency is defined and which population is studied. FAERS adverse event monitoring captures substantial reports of peripheral neuropathy, anemia, and cognitive complaints in long-term metformin users — symptoms that map directly to B12 deficiency. B12 biomarker analysis establishes the optimal range at 500-800 pg/mL, significantly above the standard laboratory floor of 200 pg/mL. The gap is clinically critical: a patient at 250 pg/mL is flagged as "normal" by most labs but is already functionally insufficient for neurological protection. Methylmalonic acid (MMA) testing provides a more sensitive functional assessment when serum B12 results are borderline.

[3]

How It Works

Metformin depletes B12 through a specific mechanism in the terminal ileum where B12 absorption occurs. The intrinsic factor-B12 complex binds to cubilin receptors on ileal enterocytes, and this binding step is calcium-dependent — it requires calcium ions to stabilize the receptor interaction. Metformin accumulates in the gut wall at concentrations 30-300 times higher than plasma levels, where it disrupts calcium-dependent membrane processes. By interfering with the calcium signaling that cubilin requires, metformin blocks the final absorption step even though intrinsic factor and B12 are both present. This explains why the depletion is different from PPI-induced B12 deficiency: PPIs prevent B12 from being released from food proteins (an acid-dependent step), while metformin blocks the ileal uptake of already-freed B12 (a calcium-dependent step). Importantly, supplemental calcium can partially reverse the effect — a clinical finding that confirms the mechanism and informs the treatment approach.

[4]

What to Do

Test serum B12 at baseline before starting metformin, at 12 months, and annually thereafter. Target the optimal range of 500-800 pg/mL rather than the laboratory floor of 200 pg/mL. If B12 levels drop below 500 pg/mL, start supplementation immediately with high-dose oral B12 at 1,000-2,000 mcg daily — at this dose, roughly 1% is absorbed through passive diffusion independent of the calcium-dependent pathway that metformin impairs. Sublingual and intramuscular B12 formulations also bypass the intestinal absorption bottleneck. An interesting calcium connection: taking metformin with calcium supplements or calcium-rich meals may partially offset the B12 absorption interference, since supplemental calcium restores some of the calcium-dependent cubilin receptor function. Request methylmalonic acid testing if B12 is borderline (200-500 pg/mL) — elevated MMA confirms functional deficiency even before serum B12 looks clearly abnormal. Because metformin also depletes folate through the same intestinal mechanism, check both vitamins together.

[05]

Related Questions

[06]

References

  1. [1]Comparative Toxicogenomics Database (CTD). Metformin pharmacological profile. 649 RCTs across 1,319,946 patients, 301 meta-analyses. 2026.
  2. [2]PubMed indexed literature. Metformin pharmacology and B12 interactions. 10,623 indexed articles. National Library of Medicine.
  3. [3]FAERS Adverse Event Database. Metformin post-market safety surveillance. FDA 2026.
  4. [4]Aroda VR, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. PMID: 26900641.
  5. [5]de Jager J, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ. 2010;340:c2181. PMID: 20488910.
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Check What YOUR Medications Deplete

Free. No signup. 10 seconds.

Check Now →